|
NDST1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.22921681114485E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.28634946717466E-12 |
| Normal-vs-Stage2 |
3.69629999941168E-08 |
| Normal-vs-Stage3 |
6.99769999945588E-07 |
| Normal-vs-Stage4 |
2.12710000002669E-06 |
| Stage1-vs-Stage2 |
4.751400E-01 |
| Stage1-vs-Stage3 |
7.709400E-01 |
| Stage1-vs-Stage4 |
2.249000E-01 |
| Stage2-vs-Stage3 |
4.706000E-01 |
| Stage2-vs-Stage4 |
3.823400E-01 |
| Stage3-vs-Stage4 |
2.134200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22621920897836E-12 |
| Normal-vs-AfricanAmerican |
1.37050000237338E-08 |
| Normal-vs-Asian |
2.544400E-03 |
| Caucasian-vs-AfricanAmerican |
2.945000E-01 |
| Caucasian-vs-Asian |
9.381800E-01 |
| AfricanAmerican-vs-Asian |
6.641800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62503344114384E-12 |
| Normal-vs-Female |
1.93316999999027E-05 |
| Male-vs-Female |
4.876900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.77379999974659E-07 |
| Normal-vs-Extreme_Weight |
2.95152791096598E-12 |
| Normal-vs-Obese |
1.75790004774967E-09 |
| Normal-vs-Extreme_Obese |
6.29489999999233E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.742200E-01 |
| Normal_Weight-vs-Obese |
8.586600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.425800E-01 |
| Extreme_Weight-vs-Obese |
1.164360E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.859200E-01 |
| Obese-vs-Extreme_Obese |
5.907600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.812400E-04 |
| Normal-vs-Age(41-60Yrs) |
9.50630000273733E-08 |
| Normal-vs-Age(61-80Yrs) |
3.33066907387547E-16 |
| Normal-vs-Age(81-100Yrs) |
2.30560000002988E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.791200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.607700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.863020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.288000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.105200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.633400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.63613567139009E-12 |
| Normal-VS-Type2 PRCC |
3.4028335704761E-13 |
| Normal-VS-KIRP CIMP |
1.683500E-03 |
| Normal-VS-Unclassified PRCC |
7.124500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.379400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.055400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.835600E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.117000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.560400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.459000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.75420020123818E-10 |
| Normal-vs-N1 |
2.48919999945585E-07 |
| Normal-vs-N2 |
2.450400E-02 |
| N0-vs-N1 |
4.096800E-01 |
| N0-vs-N2 |
4.668200E-01 |
| N1-vs-N2 |
7.672000E-01 |
|
|
